# Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery

> **NCT07699601** · PHASE2,PHASE3 · RECRUITING · sponsor: **Shanghai Huilun Pharmaceutical Co., Ltd.** · enrollment: 330 (estimated)

## Conditions studied

- Postoperative Pain

## Interventions

- **DRUG:** HL-1186
- **DRUG:** HL-1186 placebo
- **DRUG:** Oxycodone-Acetaminophen
- **DRUG:** Oxycodone-Acetaminophen Matching Placebo

## Key facts

- **NCT ID:** NCT07699601
- **Lead sponsor:** Shanghai Huilun Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-05-09
- **Primary completion:** 2026-10
- **Final completion:** 2026-12
- **Target enrollment:** 330 (ESTIMATED)
- **Last updated:** 2026-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07699601

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07699601, "Evaluate the Safety and Efficacy of HL-1186 Tablet for Postoperative Analgesia in Orthopedic Surgery". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07699601. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*